Kimberly Chong

Array ( [id] => 4711619 [patent_doc_number] => 20080300145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'In vivo high throughput selection of RNAi probes' [patent_app_type] => utility [patent_app_number] => 11/981269 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15969 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300145.pdf [firstpage_image] =>[orig_patent_app_number] => 11981269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753187 [patent_doc_number] => 20080161262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Compositions and Methods for the Systemic Treatment of Arthritis' [patent_app_type] => utility [patent_app_number] => 11/925538 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6457 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161262.pdf [firstpage_image] =>[orig_patent_app_number] => 11925538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916488 [patent_doc_number] => 20080097089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'siRNA targeting deubiqutination enzymes' [patent_app_type] => utility [patent_app_number] => 11/977558 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 48201 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20080097089.pdf [firstpage_image] =>[orig_patent_app_number] => 11977558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620910 [patent_doc_number] => 08791084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions' [patent_app_type] => utility [patent_app_number] => 12/447238 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12738 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12447238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343484 [patent_doc_number] => 20090182134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'siRNA targeting phosphatases' [patent_app_type] => utility [patent_app_number] => 11/977406 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 60770 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182134.pdf [firstpage_image] =>[orig_patent_app_number] => 11977406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720104 [patent_doc_number] => 20080242627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'NOVEL RNA INTERFERENCE METHODS USING DNA-RNA DUPLEX CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 11/871004 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21983 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242627.pdf [firstpage_image] =>[orig_patent_app_number] => 11871004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969079 [patent_doc_number] => 20110150897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'INFLUENZA TARGETS' [patent_app_type] => utility [patent_app_number] => 12/445228 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 200 [patent_figures_cnt] => 200 [patent_no_of_words] => 6329 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12445228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617405 [patent_doc_number] => 20100003299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'RNAi Methods and Compositions for Stimulating Proliferation of Cells with Adherent Functions' [patent_app_type] => utility [patent_app_number] => 12/446740 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10735 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003299.pdf [firstpage_image] =>[orig_patent_app_number] => 12446740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245052 [patent_doc_number] => 08609332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Assay' [patent_app_type] => utility [patent_app_number] => 12/311192 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 17162 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12311192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4581234 [patent_doc_number] => 07834171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Modified polynucleotides for reducing off-target effects in RNA interference' [patent_app_type] => utility [patent_app_number] => 11/857732 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 41 [patent_no_of_words] => 28560 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834171.pdf [firstpage_image] =>[orig_patent_app_number] => 11857732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270361 [patent_doc_number] => 08211865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Inhibition of ornithine aminotransferase for the treatment of proliferative disorders' [patent_app_type] => utility [patent_app_number] => 12/377889 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10990 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12377889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104259 [patent_doc_number] => 08153776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Methods and compositions for RNA interference' [patent_app_type] => utility [patent_app_number] => 11/894676 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 107 [patent_no_of_words] => 41047 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153776.pdf [firstpage_image] =>[orig_patent_app_number] => 11894676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658089 [patent_doc_number] => 20080026951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods and Compositions Involving microRNA' [patent_app_type] => utility [patent_app_number] => 11/837495 [patent_app_country] => US [patent_app_date] => 2007-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 56551 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026951.pdf [firstpage_image] =>[orig_patent_app_number] => 11837495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845837 [patent_doc_number] => 20080182245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Methods and Compositions Involving MicroRNA' [patent_app_type] => utility [patent_app_number] => 11/837494 [patent_app_country] => US [patent_app_date] => 2007-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 56568 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182245.pdf [firstpage_image] =>[orig_patent_app_number] => 11837494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765554 [patent_doc_number] => 20080176766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/837487 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 69305 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176766.pdf [firstpage_image] =>[orig_patent_app_number] => 11837487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451250 [patent_doc_number] => 07964574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes' [patent_app_type] => utility [patent_app_number] => 11/834550 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 33 [patent_no_of_words] => 5861 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964574.pdf [firstpage_image] =>[orig_patent_app_number] => 11834550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296271 [patent_doc_number] => 20100160412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHODS OF MODULATING METABOLIC MEMORY' [patent_app_type] => utility [patent_app_number] => 12/375901 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11855 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160412.pdf [firstpage_image] =>[orig_patent_app_number] => 12375901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350187 [patent_doc_number] => 20090005548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'siRNA targeting nuclear receptor interacting protein 1 (NRIP1)' [patent_app_type] => utility [patent_app_number] => 11/881777 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35006 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005548.pdf [firstpage_image] =>[orig_patent_app_number] => 11881777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771404 [patent_doc_number] => 20080057062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Agent for Inducing senescence and apoptosis of cancer cell' [patent_app_type] => utility [patent_app_number] => 11/778763 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3128 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057062.pdf [firstpage_image] =>[orig_patent_app_number] => 11778763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547311 [patent_doc_number] => 20100016405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Compositions and Methods for Inhibiting Expression of the MYC Gene' [patent_app_type] => utility [patent_app_number] => 12/373039 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12522 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016405.pdf [firstpage_image] =>[orig_patent_app_number] => 12373039 [rel_patent_id] =>[rel_patent_doc_number] =>)